Renalytix partners with Tempus AI to expand kidney disease testing
Go back to Renalytix partners with Tempus AI to expand kidney disease testing| Oppenheimer Real Estate Fund Class N (NASDAQ: RENX) | Delayed: 2.06 +0.08 (4.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.98 | 52 Week High | $18.34 | |||
| Open | $1.98 | 52 Week Low | $14.92 | |||
| Day High | $2.08 | P/E | N/A | |||
| Day Low | $1.94 | EPS | $0.00 | |||
| Volume | 219,735 | |||||
| (AMEX: RNLXY) | Delayed: 3.87 +1.23 (46.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.64 | 52 Week High | $ | |||
| Open | $2.80 | 52 Week Low | $ | |||
| Day High | $3.93 | P/E | N/A | |||
| Day Low | $2.80 | EPS | $ | |||
| Volume | 26,195 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 62.27 -0.78 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.05 | 52 Week High | $0.45 | |||
| Open | $65.64 | 52 Week Low | $0.37 | |||
| Day High | $65.79 | P/E | N/A | |||
| Day Low | $61.22 | EPS | $-0.31 | |||
| Volume | 6,236,939 | |||||

